Oxidized cholesterol is present in significant quantities in the typical Western diet. When ingested, oxidized cholesterol is absorbed by the small intestine and incorporated into both chylomicrons and LDL resulting in LDL which is more susceptible to further oxidation. Feeding studies in animal models and epidemiological studies in humans have suggested that oxidized cholesterol in the diet increases the development of atherosclerosis.
Introduction
There is strong evidence that oxidized lipoproteins play a key role in the pathogenesis of atherosclerosis (1, 2) , but the site and mechanisms by which lipoproteins are oxidized is still not well understood. There are considerable data demonstrating that lipoproteins are oxidized locally in the intima of the arterial wall (1) (2) (3) (4) , as well as evidence that oxidized lipoproteins are present in human serum (5, 6) . These circulating oxidized lipoproteins can be taken up by the arterial wall and thereby contribute to the levels of oxidized lipoproteins in the intima. Moreover, these partially oxidized lipoproteins may be much more susceptible to further oxidation in the arterial wall (7) . However, the source of oxidized lipoproteins in the serum is not known. We have been focusing our studies on the role of diet in contributing to the levels of oxidized lipoproteins in the circulation of humans.
The typical Western diet contains substantial quantities of oxidized cholesterol (8) (9) (10) (11) (12) (13) and studies in humans have shown that this oxidized cholesterol is absorbed by the small intestine and then incorporated into lipoproteins (7) . Moreover, we have demonstrated that oxidized cholesterol in the diet is incorporated not only into chylomicrons but also into endogenous LDL (7) . Thus, the levels of oxidized cholesterol in the circulation are influenced by the quantity of oxidized cholesterol in the diet. Finally, studies by our laboratory have shown in mouse (14) and rabbit models (15) of atherosclerosis by guest, on October 14, 2017 www.jlr.org Downloaded from meal. Both compounds were purchased from Steraloids Inc. (Newport, RI) and were selected because they are the major oxidized cholesterol components formed in heated or stored foods (8) (9) (10) (11) (12) (13) and are efficiently absorbed as indicated by studies in experimental animals (18) and humans (7) .
After a 12-h fast, 5 subjects were given a dose of 400 mg α-epoxy cholesterol dissolved in 50 ml olive oil and added to 100 g of carbohydrate (mashed potatoes). In a separate study, 4 subjects, were administered 7-keto cholesterol instead of α-epoxy cholesterol. The dose and experimental procedures were identical for both oxidized cholesterol studies. Two subjects participated in both the α-epoxy cholesterol and 7-keto cholesterol feeding studies. This absorption study was carried out in subjects before and after the administration of ezetimibe for 30 days (10 mg daily including the day of the experiment). Thus, the subjects were given the test meal at day 0 and again at day 30 and ezetimibe was administered during the time period between day 0 and day 30. The oxidized cholesterol absorption after the same test meal was then compared before and after the administration of the drug. Each subject served as his/her own control. The subjects tolerated the test meal well, and none had gastrointestinal symptoms. At 2, 4, 6, and 8 h after the consumption of the test meal, 50 ml blood samples were obtained for the determination of serum triglycerides, cholesterol and oxidized cholesterol levels. All serum samples were stored in ice and contained 10 µM EDTA and 5 µM BHT throughout the sample processing. The α-epoxy cholesterol and 7-keto cholesterol levels were measured in serum before and after the ezetimibe administration and the amount of oxidized cholesterol was expressed as µg oxidized cholesterol per dL of serum. The subjects were not permitted to consume any food for the 8 h test period. Water was allowed ad libidum.
Lipoprotein isolation and characterization.
The oxidized cholesterol content was determined in CM/RM and LDL fractions before and after the administration of ezetimibe. These lipoprotein fractions were isolated by density centrifugation as described by us previously (7).
Analytical methods.
Total cholesterol, triglyceride, and HDL cholesterol levels in serum were measured using an Infinity kit from Thermo Electron TR 13421 (Louisville, CO 80027).
LDL was calculated using the Friedewald formula. Alpha-epoxy and 7-keto cholesterol in serum and serum lipoprotein fractions was determined by GLC using the procedure described by Hughes et al (19) and previously by us (7, 14, 15) . Lipid samples were derivatized with Sylon BFT and injected into a gas chromatograph 
Statistics.
Data are presented as mean+SEM. The mean differences between groups were assessed with a paired Student's t-test. Significance was expressed as p<0.05.
Results.
Subjects. Table 1 summarizes lipid values of the subjects before and after the administration of ezetimibe 10 mg daily for 30 days. As expected, the serum cholesterol and LDL cholesterol levels were reduced in subjects that were taking ezetimibe. HDL levels increased in the ezetimibe group, but the difference did not reach statistical significance. No significant change was detected in triglyceride levels.
Dietary oxidized cholesterol incorporation into serum and serum lipoproteins in subjects before and after the administration of ezetimibe.
We next examined the time course of the increase in serum α-epoxy cholesterol levels after feeding the test meal before and after the subjects were administered ezetimibe 10 mg daily for 30 days. As shown in Fig. 1A , after feeding a test meal containing α-epoxy cholesterol, the levels of α-epoxy cholesterol in the serum rapidly increased reaching a peak value at 4 h and remained elevated during the 8 h test period. These data are in agreement with our previously published results (7) . In subjects that received ezetimibe for 30 days, serum oxidized cholesterol content was lower at all time points studied. When areas under the clearance curves were compared (Fig. 1B) , a 51 % reduction (53.2+7.3 for controls and 25.9+9.2 for ezetimibe treated as expressed in area units) was observed in the ezetimibe treated group (p=0.01).
After the administration of the test meal, over an 8 h period, α-epoxy cholesterol was present in both, CM/RM and LDL lipoprotein fractions. Fig. 2A shows the time course of appearance of α-epoxy cholesterol in serum CM/RM after feeding α-epoxy cholesterol before and after ezetimibe administration. When the areas under the clearance curve were compared (Fig. 2B) , there was a 64 % decrease (p=0.019) in the α-epoxy cholesterol in subjects treated with ezetimibe. ( 10.8 + 1.4 for controls and 3.9+ 1.8 for the ezetimibe treated group). Similar results were found in the serum LDL fraction (Fig. 3A) . As shown in Fig. 3B , the area under the clearance curve for the control subjects was decreased by 52 % (13.8+2.8 and 6.6+1.7 for subjects treated with ezetimibe; p=0.048). We next determined the effect of ezetimibe on the serum levels of another oxidized cholesterol (7-keto cholesterol) present in high quantities in the typical Western diet. Fig. 5A demonstrates that similar to α-epoxy cholesterol, there was a significant reduction in 7-keto cholesterol levels in the serum after the subjects were treated with ezetimibe for 30 days. The area under the clearance curve was reduced by 48 % in the ezetimibe treated group (49.9+3.4 for controls and 25.9+5.9 for ezetimibe treated subjects; p=0.013) (Fig. 5B) . Studies in both humans (7) and animals (14, 15, 21, 22) have demonstrated that the small intestine absorbs oxidized cholesterol in the diet. The absorbed oxidized cholesterol is incorporated into chylomicrons and secreted into the lymph.
Chylomicrons containing oxidized cholesterol are metabolized similarly to "normal" chylomicrons with the oxidized cholesterol being primarily delivered to the liver (23) .
Recent studies by our laboratory have shown that in humans, oxidized cholesterol in the diet is incorporated into post-priandial chylomicrons (7) . Moreover, we also found that oxidized cholesterol was present in endogenous lipoproteins, particularly LDL (7).
Furthermore, the LDL containing oxidized cholesterol was more susceptible to further oxidation than "normal" LDL (7). demonstrated an increase in atherosclerotic lesion in the aortas of White Carneau pigeons and squirrel monkeys, respectively. In our studies, we demonstrated that oxidized cholesterol in the diet increased atherosclerosis when fed to rabbits (14) , apolipoprotein E deficient mice, and LDL receptor deficient mice (15) . In humans there is a paucity of data on the effect of oxidized cholesterol in the diet on atherosclerosis. In the absence of other risk factors, Indians living in London have a higher incidence of atherosclerosis compared to non-Indians and this increase has been proposed to be due to the ingestion of ghee (heated butter which is very rich in oxidized cholesterol containing up to 12% of total cholesterol as oxysterols) (26). Similarly, in India individuals who consume greater than 1 kg of ghee per month had a 4-fold increase in the rate of heart disease (27). In addition to these studies, epidemiological studies have shown an association of oxidized cholesterol in the serum and atherosclerosis (28). It was shown that an increase in plasma 7 β hydroxy cholesterol in Lithuanian men compared to Swedish men was associated with a 4-fold increase in heart disease.
Additionally, it has been demonstrated that coronary atherosclerosis is reflected by autoantibodies against oxidized LDL and oxidized cholesterol in the serum (29). While these associations are supportive of the hypothesis that oxidized cholesterol in the diet predisposes to atherosclerosis it is clear that other factors could be the basis for the increase in atherosclerosis in these studies. However, taking the animal data and human data in total it appears that oxidized cholesterol in the diet might increase In the present study we demonstrated that ezetimibe 10mg per day for one month markedly reduced the levels of oxidized cholesterol in the serum after a feeding a test meal containing either α-epoxycholesterol or 7-ketocholesterol, two of the predominant oxysterols found in the diet. Moreover, the decrease in oxidized cholesterol in the serum was due to a decrease in the incorporation of dietary oxidized cholesterol into both chylomicrons and LDL. That this decrease in oxidized cholesterol in the serum was due to ezetimibe inhibiting the absorption of dietary oxidized cholesterol is suggested by the absence of changes in postprandial triglyceride levels with ezetimibe treatment. If the marked reduction in oxidized cholesterol levels was due to enhanced clearance one would have expected a concomitant reduction in postpriandial triglyceride levels.
In summary the present study demonstrates that ezetimibe markedly decreases the levels of oxidized cholesterol in lipoproteins following the ingestion of diet that contains oxidized cholesterol. Whether this decrease in circulating oxidized cholesterol will prevent or delay the development of atherosclerosis remains to be determined. control subjects were administered a test meal containing 7− keto cholesterol and the quantity of 7-keto cholesterol in serum was determined before and after treatment with ezetimibe (10 mg/day for 30 days). The levels of 7-keto cholesterol in serum were measured using GLC and are expressed as µg/dL serum (A).
The areas under the clearance curves were measured in arbitrary units and the significance of the differences of areas under the curve was determined (B). p=0.013.
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